AAAAAA
Results: 1-25/32
Authors:
Yang, X
Yan, L
Davidson, NE
Citation: X. Yang et al., DNA methylation in breast cancer, ENDOCR-R CA, 8(2), 2001, pp. 115-127
Authors:
Yan, L
Yang, XW
Davidson, NE
Citation: L. Yan et al., Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer, J MAMMARY G, 6(2), 2001, pp. 183-192
Authors:
Hahm, HA
Dunn, VR
Butash, KA
Deveraux, WL
Woster, PM
Casero, RA
Davidson, NE
Citation: Ha. Hahm et al., Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines, CLIN CANC R, 7(2), 2001, pp. 391-399
Authors:
Davidson, NE
Wolff, AC
Citation: Ne. Davidson et Ac. Wolff, The use of anthracyclines and taxanes for adjuvant therapy of breast cancer, BREAST, 10, 2001, pp. 90-95
Authors:
Kiddle, G
Bennett, RN
Botting, NP
Davidson, NE
Robertson, AAB
Wallsgrove, RM
Citation: G. Kiddle et al., High-performance liquid chromatographic separation of natural and synthetic desulphoglucosinolates and their chemical validation by UV, NMR and chemical ionisation-MS methods, PHYTOCH AN, 12(4), 2001, pp. 226-242
Authors:
Armstrong, DK
Davidson, NE
Citation: Dk. Armstrong et Ne. Davidson, Dose intensity for breast cancer, ONCOLOGY-NY, 15(6), 2001, pp. 701
Authors:
Evron, E
Dooley, WC
Umbricht, CB
Rosenthal, D
Sacchi, N
Gabrielson, E
Soito, AB
Hung, DT
Ljung, BM
Davidson, NE
Sukumar, S
Citation: E. Evron et al., Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR, LANCET, 357(9265), 2001, pp. 1335-1336
Authors:
Dees, EC
Davidson, NE
Citation: Ec. Dees et Ne. Davidson, Ovarian ablation as adjuvant therapy for breast cancer, SEMIN ONCOL, 28(4), 2001, pp. 322-331
Authors:
Davidson, NE
Rutherford, TJ
Botting, NP
Citation: Ne. Davidson et al., Synthesis, analysis and rearrangement of novel unnatural glucosinolates, CARBOHY RES, 330(3), 2001, pp. 295-307
Authors:
Yang, XW
Phillips, DL
Ferguson, AT
Nelson, WG
Herman, JG
Davidson, NE
Citation: Xw. Yang et al., Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells, CANCER RES, 61(19), 2001, pp. 7025-7029
Authors:
Davidson, NE
Mills, G
Stern, H
Leggett, T
Citation: Ne. Davidson et al., Forward-backward assimilation, prediction and dynamics for the southeast Australia floods of October 1993, AUST METEOR, 50(3), 2001, pp. 205-224
Authors:
Davidson, NE
Citation: Ne. Davidson, Combined endocrine therapy for breast cancer - New life for an old idea?, J NAT CANC, 92(11), 2000, pp. 859-860
Authors:
Hahm, HA
Armstrong, DK
Chen, TL
Grochow, L
Passos-Coelho, J
Goodman, SN
Davidson, NE
Kennedy, MJ
Citation: Ha. Hahm et al., Novobiocin in combination with high-dose chemotherapy for the treatment ofadvanced breast cancer: A phase 2 study, BIOL BLOOD, 6(3A), 2000, pp. 335-343
Authors:
Jackisch, C
Hahm, HA
Tombal, B
McCloskey, D
Butash, K
Davidson, NE
Denmeade, SR
Citation: C. Jackisch et al., Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells, CLIN CANC R, 6(7), 2000, pp. 2844-2850
Authors:
McCloskey, DE
Woster, PM
Casero, RA
Davidson, NE
Citation: De. Mccloskey et al., Effects of the polyamine analogues N-1-Ethyl-N-11-((cyclopropyl)methyl)-4,8-diazaundecane and N-1-ethyl-N-11-((cycloheptyl)methyl)-4,8-diazaundecane in human prostate cancer cells, CLIN CANC R, 6(1), 2000, pp. 17-23
Authors:
Carlson, RW
Anderson, BO
Bensinger, W
Cox, CE
Davidson, NE
Edge, SB
Farrar, WB
Goldstein, LJ
Gradishar, WJ
Lichter, AS
McCormick, B
Nabell, LM
Reed, EC
Silver, SM
Smith, ML
Somlo, G
Theriault, R
Ward, JH
Winer, EP
Wolff, A
Citation: Rw. Carlson et al., NCCN Practice Guidelines for breast cancer, ONCOLOGY-NY, 14(11A), 2000, pp. 33-49
Authors:
Huff, CA
Carducci, M
Davidson, NE
Citation: Ca. Huff et al., Follow-up care for cancer: Making the benefits equal the cost, ONCOLOGY-NY, 14(10), 2000, pp. 1502
Authors:
Wolff, AC
Davidson, NE
Citation: Ac. Wolff et Ne. Davidson, Primary systemic therapy in operable breast cancer, J CL ONCOL, 18(7), 2000, pp. 1558-1569
Authors:
Davidson, NE
Weber, HC
Citation: Ne. Davidson et Hc. Weber, The BMRC high-resolution tropical cyclone prediction system: TC-LAPS, M WEATH REV, 128(5), 2000, pp. 1245-1265
Authors:
Yang, XW
Ferguson, AT
Nass, SJ
Phillips, DL
Butash, KA
Wang, SM
Herman, JG
Davidson, NE
Citation: Xw. Yang et al., Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition, CANCER RES, 60(24), 2000, pp. 6890-6894
Authors:
Nass, SJ
Herman, JG
Gabrielson, E
Iversen, PW
Parl, FF
Davidson, NE
Graff, JR
Citation: Sj. Nass et al., Aberrant methylation of the estrogen receptor and E-cadherin 5 ' CpG islands increases with malignant progression in human breast cancer, CANCER RES, 60(16), 2000, pp. 4346-4348
Authors:
van der Wall, E
Horn, T
Bright, E
Passos-Coehlo, JL
Bond, S
Clarke, B
Altomonte, V
McIntyre, K
Vogelsang, G
Noga, SJ
Davis, JM
Thomassen, J
Ohly, K
Lee, SM
Fetting, J
Armstrong, DK
Davidson, NE
Hess, AD
Kennedy, MJ
Citation: E. Van Der Wall et al., Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells, BR J CANC, 83(11), 2000, pp. 1405-1411
Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment
Authors:
Davidson, NE
Hahm, HA
McCloskey, DE
Woster, PM
Casero, RA
Citation: Ne. Davidson et al., Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment, ENDOCR-R CA, 6(1), 1999, pp. 69-73
Authors:
Nass, SJ
Ferguson, AT
El-Ashry, D
Nelson, WG
Davidson, NE
Citation: Sj. Nass et al., Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells, ONCOGENE, 18(52), 1999, pp. 7453-7461
Authors:
Carlson, RW
Anderson, BO
Bensinger, W
Cox, C
Davidson, NE
Edge, SB
Farrar, WB
Goldstein, LJ
Gradishar, WJ
Lichter, AS
Mccormick, B
Nabell, LM
Reed, EC
Silver, SM
Smith, MLP
Somlo, G
Theriault, RL
Winer, EP
Citation: Rw. Carlson et al., Update: NCCN practice guidelines for the treatment of breast cancer, ONCOLOGY-NY, 13(11A), 1999, pp. 187-212